- Benzinga Cannabis Daily
- Posts
- đź’š Committed
đź’š Committed
3 in 10 marijuana shoppers are strain-loyal. Plus, Tilray and Curaleaf ramp up their presence in Europe.
Happy Thursday, Cannabis Investors! 3 in 10 marijuana shoppers are in a committed relationship with their “buds” and never change their weed retail choices. Learn about strain loyalty here.
Plus, weed giants Tilray and Curaleaf are ramping up their presence in Europe. Here's why.
Also, check out the newest episode of Cannabis Insider, also available on Apple and Spotify.*
Puff Pass: Did someone forward you this email? Click here to get automatically subscribed.
TOP STORY
Briefly: U.S. Vice President Kamala Harris plans to meet rapper Fat Joe and several people pardoned by the Biden administration for marijuana-related convictions for a White House public discussion about criminal justice reform.
So Basically: The meeting follows President Biden’s cannabis reform promise in his State of the Union speech last Thursday. Biden reiterated his stance that no one should be incarcerated for possessing cannabis.
So What? Five-time Grammy nominee Fat Joe is a proponent of criminal justice reform. Harris aims to gain deeper insights by reaching out to federal cannabis offenders pardoned in October 2022 and December 2023.
WHERE DEALS GET DONE
The Benzinga Cannabis Capital Conference is where deals get done.
With 2,000+ decision-makers in one room, attendees have the chance to engage in a year's worth of networking in just two days. More than 100 CEOs and 200 Investors confirmed for Investment and Branding on April 16th - 18th at The Diplomat Beach Resort in Hollywood, FL.
Boris Jordan, executive chairman of Curaleaf, to deliver Keynote Speech.
ZINGERS
$250k in “the garbage”: Disabled combat veteran slams NJ Cannabis Commission for ignoring her for 2 painful years
Verano Holdings worth $2.1B, outprices its expected 2024 earnings
POSaBIT aims to enhance trading liquidity in cannabis after Hypur Deal, CEO calls it 'a natural continuation of plan'
Planet 13 stays green amid $23M revenue and red ink, Q4 2023 financial results
ONE FOR THE ROAD
MariMed Wholesale Revenue Up 48% Driven By Top Marijuana Brands: Why Is This Weed Stock Undervalued?
Briefly: MariMed, a notable player in the U.S. cannabis market, recently reported its financial results and guidance.
So Basically: In a detailed analysis, Pablo Zuanic, senior analyst at Zuanic & Associates, highlighted the company's position in a competitive market.
Specifically: Despite trading at 4.6x EBITDA — below the Multi-State Operator average of 7.3x — MariMed's brand portfolio shines, boasting a 48% increase in wholesale revenue for 2023 and projecting over 20% growth for 2024.
So What? The company's adjusted EBITDA is anticipated to be around $25 million, slightly up from the previous year, but still under the expected $38 million.
WHERE DEALS GET DONE
The Benzinga Cannabis Capital Conference is where deals get done.
With 2,000+ decision-makers in one room, attendees have the chance to engage in a year's worth of networking in just two days. More than 100 CEOs and 200 Investors confirmed for Investment and Branding on April 16th - 18th at The Diplomat Beach Resort in Hollywood, FL.
Boris Jordan, executive chairman of Curaleaf, to deliver Keynote Speech.
KEEP READING
Before you go, be sure to subscribe to our other newsletters:
Ring The Bell: If you have to pick just one daily financial newsletter, it’s not a choice. Subscribe here.
The Street Sheet: A Wall Street cheat sheet, delivered every Sunday directly to your inbox. One-click subscribe here.
Future Finance: TradFi is tired. Wake up to the future of finance with this midday fintech and crypto letter. Subscribe here.
The Flag: Top takes from Washington to Wall Street impacting policy and your portfolio. One-click subscribe here.